In mouse models of melanoma, breast cancer, and colon cancer, PEGKYNase (modified with polyethylene glycol (PEG) to enhance enzyme stability and half‐life) can reduce serum Kyn, increase AA levels, and simultaneously increase the number of CD8+ T cells infiltrating the tumor microenvironment, reducing tumor volume [103]. The gene discussed is CD8A; the disease is neoplasm.